FDA Takes Hard Look at CBD
CBD products have swamped the market due to change in federal law, not because of new medical evidence
ACP Issues Position on Response to Physician Impairment
Rehabilitated doctors should be reintegrated into practice as long as patient safety not compromised
May 2019 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for May 2019. This roundup includes...
Guidelines Updated for Radiotherapy After Prostatectomy
Updates include adjuvant radiotherapy for patients with adverse pathologic findings, hormonal therapies
Lupus Manifestations Appear to Differ by Race, Ethnicity
Increased risk for severe manifestations seen among blacks, Hispanics, and Asians/Pacific Islanders
Excess Cause-Specific Mortality Tied to Chronic Proton Pump Inhibitor Use
Excess mortality due to CVD, CKD, upper GI cancer for those with no indication for PPI use
2007 to 2017 Saw Decline in Number of U.S. Pathologists
At the same time, the cancer-related diagnostic workload rose 42 percent per pathologist
High Costs Associated With Physician Burnout in U.S.
Nationally, about $4.6 billion in costs are related to physician turnover, reduced clinical hours
Early-Onset CRC Rising Fastest for Whites in Western States
Neither increases in prevalence of obesity nor heavy alcohol consumption correlated with CRC trends
Ibrutinib, Venetoclax Active in High-Risk, Seniors With CLL
Findings seen in phase 2 study of combo regimen for first-line treatment of chronic lymphocytic leukemia
